undamentalytics Newsletter
Sign in

Pacs Group, Inc. income statement

In fiscal 2025, Pacs Group, Inc. reported revenue of $5.29bn, up 29.3% on the year before, operating income of $310m (a 5.9% margin) and net income of $192m, or $1.22 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2,4223,1114,0905,2895,551
General and administrative149214344415443
Operating income229208123310410
Interest expense2650442830
Income before tax207157102284383
Income tax57444693114
Net income15011356192269
Diluted EPS$1.17$0.88$0.38$1.22$1.74
Diluted shares (average)129m129m149m157m155m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ENSG vs PACSACHC vs PACSPACS vs SGRY

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Pacs Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pacs Group, Inc.